Posted by Michael Wonder on 15 Jul 2021
Biogen Alzheimer's drug hits roadblocks with some hospitals, insurers
15 July 2021 - Biogen's Alzheimer's drug, the first new treatment for the memory-robbing disease in nearly 20 years, hit new barriers on Thursday with some large hospitals declining to use it and health insurers delaying a decision while awaiting coverage terms from Medicare.
Cleveland Clinic, one of the country’s best-known health systems, and New York's Mount Sinai Health System on Thursday confirmed they had decided not to carry the new drug, called Aduhelm.
